ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko00281	Geraniol degradation	4/245	5/7206	6.34961697028e-06
ko04512	ECM-receptor interaction	12/245	79/7206	1.23339395704e-05
ko00020	Citrate cycle (TCA cycle)	8/245	35/7206	1.69033889601e-05
ko04510	Focal adhesion	21/245	240/7206	6.09359375768e-05
ko04060	Cytokine-cytokine receptor interaction	18/245	191/7206	8.00628714862e-05
ko05146	Amoebiasis	12/245	99/7206	0.000121837976595
ko04668	TNF signaling pathway	13/245	120/7206	0.000202656413429
ko04974	Protein digestion and absorption	11/245	96/7206	0.000383998037578
ko01200	Carbon metabolism	13/245	128/7206	0.000384831159658
ko05410	Hypertrophic cardiomyopathy (HCM)	11/245	100/7206	0.000547170824899
ko00620	Pyruvate metabolism	7/245	46/7206	0.000829976268446
ko04621	NOD-like receptor signaling pathway	14/245	157/7206	0.000870265030683
ko04657	IL-17 signaling pathway	9/245	87/7206	0.00266112021483
ko05164	Influenza A	13/245	167/7206	0.00439898566466
ko05414	Dilated cardiomyopathy	10/245	112/7206	0.00463799128607
ko04210	Apoptosis	14/245	180/7206	0.00501467264642
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	8/245	79/7206	0.00517285062641
ko04932	Non-alcoholic fatty liver disease (NAFLD)	14/245	182/7206	0.0052264426153
ko00760	Nicotinate and nicotinamide metabolism	5/245	34/7206	0.00541471405904
ko04380	Osteoclast differentiation	11/245	134/7206	0.00576955865773
ko00500	Starch and sucrose metabolism	5/245	35/7206	0.00614564616934
ko00643	Styrene degradation	2/245	4/7206	0.00660163109496
ko05161	Hepatitis B	13/245	173/7206	0.00825465037117
ko05145	Toxoplasmosis	10/245	126/7206	0.010455123882
ko04920	Adipocytokine signaling pathway	8/245	89/7206	0.0104855612803
ko05321	Inflammatory bowel disease (IBD)	6/245	56/7206	0.0113816374574
ko04623	Cytosolic DNA-sensing pathway	5/245	41/7206	0.0120333304267
ko00010	Glycolysis / Gluconeogenesis	7/245	74/7206	0.0124990359875
ko05142	Chagas disease (American trypanosomiasis)	10/245	130/7206	0.0128553565303
ko00362	Benzoate degradation	2/245	6/7206	0.0157752030818
ko00071	Fatty acid degradation	5/245	45/7206	0.0175877613466
ko00260	Glycine, serine and threonine metabolism	5/245	48/7206	0.0227163586151
ko04933	AGE-RAGE signaling pathway in diabetic complications	10/245	135/7206	0.0253774147846
ko05034	Alcoholism	2/245	238/7206	0.0262662577315
ko00380	Tryptophan metabolism	5/245	50/7206	0.0266227338292
ko05010	Alzheimer's disease	13/245	202/7206	0.0269284824485
ko00640	Propanoate metabolism	4/245	34/7206	0.0271667683965
ko04662	B cell receptor signaling pathway	7/245	88/7206	0.0296511739668
ko00627	Aminobenzoate degradation	2/245	9/7206	0.0353975321221
ko00930	Caprolactam degradation	2/245	9/7206	0.0353975321221
ko00280	Valine, leucine and isoleucine degradation	5/245	54/7206	0.0356591007975
ko05120	Epithelial cell signaling in Helicobacter pylori infection	7/245	92/7206	0.0365561227453
ko05205	Proteoglycans in cancer	16/245	271/7206	0.0374739011827
ko05416	Viral myocarditis	5/245	55/7206	0.0381799101533
ko04660	T cell receptor signaling pathway	9/245	124/7206	0.0382331527327
ko05134	Legionellosis	6/245	74/7206	0.0393535945826
ko05140	Leishmaniasis	6/245	75/7206	0.0416105195554
ko05211	Renal cell carcinoma	7/245	96/7206	0.0444481326436
ko04658	Th1 and Th2 cell differentiation	7/245	96/7206	0.0444481326436
ko04064	NF-kappa B signaling pathway	7/245	96/7206	0.0444481326436
ko04630	Jak-STAT signaling pathway	9/245	132/7206	0.0454772594187